Cargando…

Ultra-low dose immunization and multi-component vaccination strategies enhance protection against malaria in mice

An effective vaccine would be a valuable tool for malaria control and elimination; however, the leading malaria vaccine in development, RTS,S/AS01, provided only partial protection in a Phase 3 trial. R21 is a next-generation RTS,S-like vaccine. We have previously shown in mice that R21 administered...

Descripción completa

Detalles Bibliográficos
Autores principales:	Collins, Katharine A., Brod, Florian, Snaith, Rebecca, Ulaszewska, Marta, Longley, Rhea J., Salman, Ahmed M., Gilbert, Sarah C., Spencer, Alexandra J., Franco, David, Ballou, W. Ripley, Hill, Adrian V. S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144388/ https://www.ncbi.nlm.nih.gov/pubmed/34031479 http://dx.doi.org/10.1038/s41598-021-90290-8

Ejemplares similares

The Threshold of Protection from Liver-Stage Malaria Relies on a Fine Balance between the Number of Infected Hepatocytes and Effector CD8(+) T Cells Present in the Liver
por: Spencer, Alexandra J., et al.
Publicado: (2017)

An in vitro assay to measure antibody-mediated inhibition of P. berghei sporozoite invasion against P. falciparum antigens
por: Rodríguez-Galán, Ana, et al.
Publicado: (2017)

Malaria vaccines: identifying Plasmodium falciparum liver-stage targets
por: Longley, Rhea J., et al.
Publicado: (2015)

Preclinical Development and Assessment of Viral Vectors Expressing a Fusion Antigen of Plasmodium falciparum LSA1 and LSAP2 for Efficacy against Liver-Stage Malaria
por: Halbroth, Benedict R., et al.
Publicado: (2020)

Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine
por: Collins, Katharine A., et al.
Publicado: (2017)

Protection from liver-stage malaria is dependent on a fine balance between the number of infected hepatocytes and effector CD8(+) T cells
por: Spencer, Alexandra, et al.
Publicado: (2014)

Comparative assessment of vaccine vectors encoding ten malaria antigens identifies two protective liver-stage candidates
por: Longley, Rhea J., et al.
Publicado: (2015)

Assessment of the Plasmodium falciparum Preerythrocytic Antigen UIS3 as a Potential Candidate for a Malaria Vaccine
por: Longley, Rhea J., et al.
Publicado: (2017)

Development of an in vitro Plasmodium parasite killing assay for the evaluation of cell-mediated immune responses following vaccination with pre-erythrocytic malaria vaccine candidates
por: Bliss, Carly M, et al.
Publicado: (2014)

Adjuvanting a viral vectored vaccine against pre-erythrocytic malaria
por: Milicic, Anita, et al.
Publicado: (2017)

Publisher Correction: Adjuvanting a viral vectored vaccine against pre-erythrocytic malaria
por: Milicic, Anita, et al.
Publicado: (2019)

Using Serological Markers for the Surveillance of Plasmodium vivax Malaria: A Scoping Review
por: Kartal, Lejla, et al.
Publicado: (2023)

Development of an In Vitro Assay and Demonstration of Plasmodium berghei Liver-Stage Inhibition by TRAP-Specific CD8(+) T Cells
por: Longley, Rhea J., et al.
Publicado: (2015)

CXCR3(+) T Follicular Helper Cells Induced by Co-Administration of RTS,S/AS01B and Viral-Vectored Vaccines Are Associated With Reduced Immunogenicity and Efficacy Against Malaria
por: Bowyer, Georgina, et al.
Publicado: (2018)

Identification of Immunodominant Responses to the Plasmodium falciparum Antigens PfUIS3, PfLSA1 and PfLSAP2 in Multiple Strains of Mice
por: Longley, Rhea J., et al.
Publicado: (2015)

Enhanced Vaccine-Induced CD8(+) T Cell Responses to Malaria Antigen ME-TRAP by Fusion to MHC Class II Invariant Chain
por: Spencer, Alexandra J., et al.
Publicado: (2014)

Combination of RTS,S and Pfs25-IMX313 Induces a Functional Antibody Response Against Malaria Infection and Transmission in Mice
por: Brod, Florian, et al.
Publicado: (2018)

Immunological mechanisms underlying protection mediated by RTS,S: a review of the available data
por: Moorthy, Vasee S, et al.
Publicado: (2009)

STING-pathway modulation to enhance the immunogenicity of adenoviral-vectored vaccines
por: Padron-Regalado, Eriko, et al.
Publicado: (2022)

Evaluation of the Efficacy of ChAd63-MVA Vectored Vaccines Expressing Circumsporozoite Protein and ME-TRAP Against Controlled Human Malaria Infection in Malaria-Naive Individuals
por: Hodgson, Susanne H., et al.
Publicado: (2015)

A Phase IIa Controlled Human Malaria Infection and Immunogenicity Study of RTS,S/AS01(E) and RTS,S/AS01(B) Delayed Fractional Dose Regimens in Malaria-Naive Adults
por: Moon, James E, et al.
Publicado: (2020)

Protective CD8(+) T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation
por: Ewer, Katie J., et al.
Publicado: (2013)

Sensitive detection of Plasmodium vivax malaria by the rotating-crystal magneto-optical method in Thailand
por: Orbán, Ágnes, et al.
Publicado: (2021)

Feasibility of ultra low-dose coronary computed tomography angiography
por: McGraw, Sloane, et al.
Publicado: (2018)

Ras1 Acts through Duplicated Cdc42 and Rac Proteins to Regulate Morphogenesis and Pathogenesis in the Human Fungal Pathogen Cryptococcus neoformans
por: Ballou, Elizabeth Ripley, et al.
Publicado: (2013)

Optimising Controlled Human Malaria Infection Studies Using Cryopreserved P. falciparum Parasites Administered by Needle and Syringe
por: Sheehy, Susanne H., et al.
Publicado: (2013)

Identification of novel Plasmodium vivax proteins associated with protection against clinical malaria
por: Mazhari, Ramin, et al.
Publicado: (2023)

Changes in Serological Immunology Measures in UK and Kenyan Adults Post-controlled Human Malaria Infection
por: Hodgson, Susanne H., et al.
Publicado: (2016)

Predicting RTS,S Vaccine-Mediated Protection from Transcriptomes in a Malaria-Challenge Clinical Trial
por: van den Berg, Robert A., et al.
Publicado: (2017)

Safety and Reactogenicity of an MSP-1 Malaria Vaccine Candidate: A Randomized Phase Ib Dose-Escalation Trial in Kenyan Children
por: Withers, Mark R, et al.
Publicado: (2006)

Insights into Long-Lasting Protection Induced by RTS,S/AS02A Malaria Vaccine: Further Results from a Phase IIb Trial in Mozambican Children
por: Guinovart, Caterina, et al.
Publicado: (2009)

Design of a phase III multicenter trial to evaluate the efficacy of the RTS,S/AS01 malaria vaccine in children across diverse transmission settings in Africa
por: Leach, Amanda, et al.
Publicado: (2011)

Rational development of a protective P. vivax vaccine evaluated with transgenic rodent parasite challenge models
por: Salman, Ahmed M., et al.
Publicado: (2017)

RTS,S/AS02A Malaria Vaccine Does Not Induce Parasite CSP T Cell Epitope Selection and Reduces Multiplicity of Infection
por: Enosse, Sonia, et al.
Publicado: (2006)

Solar inactivated Salmonella Typhimurium induces an immune response in BALB/c mice
por: Ssemakalu, Cornelius C., et al.
Publicado: (2021)

Production of a high purity, C‐tagged hepatitis B surface antigen fusion protein VLP vaccine for malaria expressed in Pichia pastoris under cGMP conditions
por: Mukhopadhyay, Ekta, et al.
Publicado: (2022)

The Ratiometric Transcript Signature MX2/GPR183 Is Consistently Associated With RTS,S-Mediated Protection Against Controlled Human Malaria Infection
por: Du, Ying, et al.
Publicado: (2020)

Vaccines against malaria
por: Hill, Adrian V. S.
Publicado: (2011)

Randomized, controlled trial of the long term safety, immunogenicity and efficacy of RTS,S/AS02(D) malaria vaccine in infants living in a malaria-endemic region
por: Abdulla, Salim, et al.
Publicado: (2013)

Technical specification for steel for ultra high vacuum components
Publicado: (1977)

Cannot write session to /tmp/vufind_sessions/sess_jgffcf1hkfhq7ve31hl2kdm5cu